A syndecan that interacts with EXTRACELLULAR MATRIX PROTEINS and plays a role CELL PROLIFERATION and CELL MIGRATION.
Syndecan 1 has been studied across 20 research domains including 🔬 Oncology, 🔬 Inflammation, ✨ Skin & Hair, 🫁 Liver & Detox, 🫘 Kidney. The primary research focus is 🔬 Oncology with 49% of studies addressing this area.
This evidence profile for Syndecan 1 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.